Love staunchly defended Oxbryta’s list price of $125,000/year, which has sparked some criticism, as GBT continues its research on additional therapies . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post Love is on the Air: The March to Cure Sickle Cell Disease appeared first on GEN – Genetic Engineering and Biotechnology News.